← Evidence map

ArticleEuropean urology2016

Words of Wisdom. Re: Nivolumab Versus Everolimus in Advanced Renal-Cell Carcinoma.

Peter F A MuldersPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 26972496